Exelixis, Inc. (EXEL): Price and Financial Metrics
EXEL Price/Volume Stats
| Current price | $35.05 | 52-week high | $36.60 |
| Prev. close | $35.19 | 52-week low | $19.20 |
| Day low | $34.97 | Volume | 2,980,600 |
| Day high | $35.52 | Avg. volume | 2,078,549 |
| 50-day MA | $28.86 | Dividend yield | N/A |
| 200-day MA | $24.32 | Market Cap | 10.01B |
EXEL Stock Price Chart Interactive Chart >
Exelixis, Inc. (EXEL) Company Bio
Exelixis is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer. The company was founded in 1994 and is based in San Francisco, California.
EXEL Price Returns
| 1-mo | 19.42% |
| 3-mo | 33.02% |
| 6-mo | 67.62% |
| 1-year | 67.06% |
| 3-year | 95.48% |
| 5-year | 112.30% |
| YTD | 46.10% |
| 2023 | 49.56% |
| 2022 | -12.25% |
| 2021 | -8.92% |
| 2020 | 13.90% |
| 2019 | -10.42% |
Continue Researching EXEL
Here are a few links from around the web to help you further your research on Exelixis Inc's stock as an investment opportunity:Exelixis Inc (EXEL) Stock Price | Nasdaq
Exelixis Inc (EXEL) Stock Quote, History and News - Yahoo Finance
Exelixis Inc (EXEL) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...